Form 8-K - Current report:
SEC Accession No. 0001641172-25-008389
Filing Date
2025-05-02
Accepted
2025-05-02 16:45:21
Documents
14
Period of Report
2025-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 80474
2 EX-10.1 ex10-1.htm EX-10.1 137119
  Complete submission text file 0001641172-25-008389.txt   427823

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ogen-20250502.xsd EX-101.SCH 3018
4 XBRL LABEL FILE ogen-20250502_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ogen-20250502_pre.xml EX-101.PRE 24167
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3699
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 25909430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)